Normal Growth despite Combined Pituitary Hormone Deficiency

Horm Res Paediatr. 2019;92(2):133-142. doi: 10.1159/000499318. Epub 2019 Apr 25.

Abstract

Background: The paradox of normal growth despite a lack of growth hormone (GH) is an unexplained phenomenon described in some pathological (sellar, suprasellar, and hypothalamic disorders) and overgrowth syndromes. It has been suggested that the paradoxical growth is due to other GH variants, GH-like moieties, prolactin, insulin, insulin-like growth factors (IGFs), and unidentified serum factors or growth mechanisms. The objective of this study was to determine the mechanism underlying this normal growth without GH.

Case description: We describe here growth, hormonal, and genetic analyses for an adolescent boy with panhypopituitarism who achieved an adult height above his genetic potential.

Results: Normal growth was observed despite low serum GH, IGF-I, IGF-II, IGF binding protein 3 (IGFBP-3) and acid labile subunit (ALS) concentrations, but the IGF-II/IGFBP-3 molar ratio was slightly high. Panhypopituitarism was associated with a heterozygous missense mutation of HESX1, with variable penetrance in heterozygous relatives. Exome analysis detected heterozygous missense mutations of various genes involved in intracellular signaling pathways. The growth-promoting activity of the patient's serum was unable to induce AKT phosphorylation in the MCF-7 cell line.

Conclusion: The high IGF-II/IGFBP-3 molar ratio was not the cause of the sustained high growth velocity, due to the low affinity of IGF-II for IGF type 1 receptor. The key finding was the HESX1 mutation, as similar cases have been described before, suggesting a common mechanism for growth without GH. However, the variable penetrance of this variant in heterozygous relatives suggests that modifier genes or mechanisms involving combinations with mutations of other genes involved in intracellular signaling pathways might be responsible.

Keywords: Combined pituitary hormone deficiency; Growth; IGF/IGFBP-3 molar ratio; Insulin-like growth factors.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Homeodomain Proteins / blood
  • Homeodomain Proteins / genetics*
  • Human Growth Hormone / blood*
  • Human Growth Hormone / genetics
  • Humans
  • Hypopituitarism* / blood
  • Hypopituitarism* / genetics
  • Hypopituitarism* / physiopathology
  • Insulin-Like Growth Factor Binding Protein 3 / genetics
  • Insulin-Like Growth Factor Binding Protein 3 / metabolism
  • Insulin-Like Growth Factor I / genetics
  • Insulin-Like Growth Factor I / metabolism
  • Insulin-Like Growth Factor II / genetics
  • Insulin-Like Growth Factor II / metabolism
  • MCF-7 Cells
  • Male
  • Mutation*

Substances

  • HESX1 protein, human
  • Homeodomain Proteins
  • IGF1 protein, human
  • IGF2 protein, human
  • IGFBP3 protein, human
  • Insulin-Like Growth Factor Binding Protein 3
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II

Supplementary concepts

  • Combined Pituitary Hormone Deficiency